Source: https://www.law.cornell.edu/cfr/text/21/26.75
Timestamp: 2016-08-27 03:08:49
Document Index: 91575337

Matched Legal Cases: ['art 26', '§ 26', '§ 26', '§ 1453', '§ 1454', '§ 1455', '§ 321', '§ 331', '§ 351', '§ 352', '§ 355', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 360', '§ 371', '§ 374', '§ 381', '§ 382', '§ 383', '§ 393', '§ 216', '§ 241', '§ 242', '§ 262', '§ 264', '§ 265', 'art 26']

21 CFR 26.75 - Suspension of recognition obligations. | US Law | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter A › Part 26 › Subpart C › Section 26.75 21 CFR 26.75 - Suspension of recognition obligations.
§ 26.75 Suspension of recognition obligations.
Either party may suspend its obligations under subpart A or B of this part, in whole or in part, if:
(a) A party suffers a loss of market access for the party's products within the scope of subpart A or B of this part as a result of the failure of the other party to fulfill its obligations under this part;
(b) The adoption of new or additional conformity assessment requirements as referenced in § 26.73(e) results in a loss of market access for the party's products within the scope of subpart B of this part because conformity assessment bodies (CAB's) designated by the party in order to meet such requirements have not been recognized by the party implementing the requirements; or
(c) The other party fails to maintain legal and regulatory authorities capable of implementing the provisions of this part.
U.S. Code: Title 15 - COMMERCE AND TRADE§ 1453 - Requirements of labeling; placement, form, and contents of statement of quantity; supplemental statement of quantity§ 1454 - Rules and regulations§ 1455 - Procedure for promulgation of regulations
U.S. Code: Title 21 - FOOD AND DRUGS§ 321 - Definitions; generally§ 331 - Prohibited acts§ 351 - Adulterated drugs and devices§ 352 - Misbranded drugs and devices§ 355 - New drugs§ 360 - Registration of producers of drugs or devices§ 360b - New animal drugs§ 360c - Classification of devices intended for human use§ 360d - Performance standards§ 360e - Premarket approval§ 360e-1§ 360f - Banned devices§ 360g - Judicial review§ 360h - Notification and other remedies§ 360i - Records and reports on devices§ 360j - General provisions respecting control of devices intended for human use§ 360l - Postmarket surveillance§ 360m - Accredited persons§ 371 - Regulations and hearings§ 374 - Inspection§ 381 - Imports and exports§ 382 - Exports of certain unapproved products§ 383 - Office of International Relations§ 393 - Food and Drug Administration
U.S. Code: Title 42 - THE PUBLIC HEALTH AND WELFARE§ 216 - Regulations§ 241 - Research and investigations generally§ 242l - International cooperation§ 262 - Regulation of biological products§ 264 - Regulations to control communicable diseases§ 265 - Suspension of entries and imports from designated places to prevent spread of communicable diseases
Title 21 published on 2015-04-01The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 26 after this date.2015-04-03; vol. 80 # 64 - Friday, April 3, 201580 FR 18087 - Food and Drug Administration Regulations; Change of Addresses; Technical Amendment